首页 > 最新文献

Regenerative Therapy最新文献

英文 中文
Research trends on platelet-rich plasma in improving ovarian dysfunction: A bibliometric and visualization analysis 富血小板血浆改善卵巢功能障碍的研究趋势:文献计量学和可视化分析
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-09-30 DOI: 10.1016/j.reth.2025.09.010
Fangyu Liu , Jiajia Li , Jin Li , Maozhuo Lan , Xiaoning Wang , Songling Zhang

Introduction

Platelet-rich plasma (PRP) has attracted attention due to its potential to restore or enhance ovarian function. However, resources for evaluating the research trends of PRP in improving ovarian dysfunction are limited. This study aims to conduct a bibliometric analysis of the relevant literature on PRP improving ovarian dysfunction, and explore the current research status, hotspots and frontiers in this field.

Methods

Studies on PRP improving ovarian dysfunction were retrieved from the Science Citation Index Extended (SCI-E) database of Web of Science (WOS). The research trends and characteristics were analyzed using visualization software such as VOSviewer, SCImago Graphica and CiteSpace.

Results

A total of 193 studies were identified. The USA, IRAN and CHINA were the most productive countries. The number of publications on PRP improving ovarian dysfunction has shown a significant upward trend since 2018. Papers published in the United States lead in terms of the number of publications, citation counts and H-index. Although the number of publications in Turkey is slightly lower than that in China, its H-index and average citations are higher than those in China. The strongest keyword is “stimulation”, and the keyword with the longest duration of an outbreak is “gonadotropins” (starting in 2010 and ending in 2018). The 5 largest co-citation clusters are as follows: menopause (#0), fertility preservation (#1), implantation failure (#3), preimplantation genetic testing (#4), stem cell therapy (#5).

Conclusions

Current research indicates that there is still great potential for the development of PRP in improving ovarian dysfunction. In the future, it is necessary to break through the current bottleneck, promote the transformation of PRP from a “potential intervention method” to a “clinical routine plan”, and provide safer and more effective treatment options for patients with decreased ovarian dysfunction and assisted reproduction.
富血小板血浆(PRP)因其具有恢复或增强卵巢功能的潜力而备受关注。然而,评估PRP在改善卵巢功能障碍方面的研究趋势的资源有限。本研究旨在对PRP改善卵巢功能障碍的相关文献进行文献计量学分析,探讨该领域的研究现状、热点和前沿。方法从Web of Science (WOS)的科学引文索引扩展(SCI-E)数据库中检索PRP改善卵巢功能障碍的研究。利用VOSviewer、SCImago Graphica、CiteSpace等可视化软件分析研究趋势和特点。结果共纳入193项研究。美国、伊朗和中国是产量最高的国家。自2018年以来,关于PRP改善卵巢功能障碍的出版物数量呈显著上升趋势。在美国发表的论文数量、被引次数和h指数均居世界前列。虽然土耳其的论文发表数量略低于中国,但其h指数和平均被引量均高于中国。最强的关键词是“刺激”,爆发持续时间最长的关键词是“促性腺激素”(从2010年开始到2018年结束)。5个最大的共被引集群如下:绝经(#0),生育能力保存(#1),植入失败(#3),植入前基因检测(#4),干细胞治疗(#5)。结论目前的研究表明,PRP在改善卵巢功能障碍方面仍有很大的发展潜力。未来需要突破目前的瓶颈,推动PRP从“潜在干预手段”向“临床常规方案”的转变,为卵巢功能减退、辅助生殖患者提供更安全、更有效的治疗选择。
{"title":"Research trends on platelet-rich plasma in improving ovarian dysfunction: A bibliometric and visualization analysis","authors":"Fangyu Liu ,&nbsp;Jiajia Li ,&nbsp;Jin Li ,&nbsp;Maozhuo Lan ,&nbsp;Xiaoning Wang ,&nbsp;Songling Zhang","doi":"10.1016/j.reth.2025.09.010","DOIUrl":"10.1016/j.reth.2025.09.010","url":null,"abstract":"<div><h3>Introduction</h3><div>Platelet-rich plasma (PRP) has attracted attention due to its potential to restore or enhance ovarian function. However, resources for evaluating the research trends of PRP in improving ovarian dysfunction are limited. This study aims to conduct a bibliometric analysis of the relevant literature on PRP improving ovarian dysfunction, and explore the current research status, hotspots and frontiers in this field.</div></div><div><h3>Methods</h3><div>Studies on PRP improving ovarian dysfunction were retrieved from the Science Citation Index Extended (SCI-E) database of Web of Science (WOS). The research trends and characteristics were analyzed using visualization software such as VOSviewer, SCImago Graphica and CiteSpace.</div></div><div><h3>Results</h3><div>A total of 193 studies were identified. The USA, IRAN and CHINA were the most productive countries. The number of publications on PRP improving ovarian dysfunction has shown a significant upward trend since 2018. Papers published in the United States lead in terms of the number of publications, citation counts and H-index. Although the number of publications in Turkey is slightly lower than that in China, its H-index and average citations are higher than those in China. The strongest keyword is “stimulation”, and the keyword with the longest duration of an outbreak is “gonadotropins” (starting in 2010 and ending in 2018). The 5 largest co-citation clusters are as follows: menopause (#0), fertility preservation (#1), implantation failure (#3), preimplantation genetic testing (#4), stem cell therapy (#5).</div></div><div><h3>Conclusions</h3><div>Current research indicates that there is still great potential for the development of PRP in improving ovarian dysfunction. In the future, it is necessary to break through the current bottleneck, promote the transformation of PRP from a “potential intervention method” to a “clinical routine plan”, and provide safer and more effective treatment options for patients with decreased ovarian dysfunction and assisted reproduction.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 802-811"},"PeriodicalIF":3.5,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145219330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing the understanding of alveolar regeneration: Global research trends, thematic evolution, and emerging frontiers 推进对牙槽骨再生的理解:全球研究趋势、专题演变和新兴前沿
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-09-30 DOI: 10.1016/j.reth.2025.09.005
Si-Cheng Zhou , Ying-Xian Dong , Jie Tian , Guo-Wei Che , Yutian Lai

Background

Alveolar regeneration represents a critical research direction in respiratory disease treatment. Despite the surge in studies following the COVID-19 pandemic, comprehensive bibliometric analysis to systematically evaluate global research trends and future directions remains lacking.

Methods

This study employed bibliometric methodology to analyze 1564 publications related to alveolar regeneration from 1974 to 2024 using the Web of Science Core Collection database. Data visualization and analysis were conducted using VOSviewer (version 1.6.19), CiteSpace (version 6.2.R3), and the biblioshiny R package.

Results

The analysis encompassed 68 countries, 1930 institutions, and 9150 researchers across 658 journals. The United States leads with 601 publications and 32,172 citations, with Harvard University as the most influential institution. The American Journal of Respiratory and Critical Care Medicine has the highest impact factor (19.3), while the American Journal of Physiology-Lung Cellular and Molecular Physiology has the most co-citations (2,402). Edward E. Morrisey is the most prolific author, and C. E. Barkauskas has the highest co-citations. Keyword analysis revealed six major research clusters: stem cells and regenerative medicine, acute lung injury and fibrosis, COVID-19-related research, chronic lung disease repair, cellular behavior and molecular mechanisms, and post-pneumonectomy regeneration. Thematic mapping indicates future research should prioritize lung injury repair mechanisms, matrix environment in tissue regeneration, stem cell therapeutics, and immune regulation in lung injury repair.

Conclusion

This first comprehensive 50-year bibliometric analysis of alveolar regeneration reveals the evolutionary trend from basic mechanistic exploration toward clinical translational applications, providing important reference for researchers and funding agencies.
背景肺泡再生是呼吸系统疾病治疗的一个重要研究方向。尽管COVID-19大流行后研究激增,但仍缺乏全面的文献计量分析来系统评估全球研究趋势和未来方向。方法采用文献计量学方法,对Web of Science Core Collection数据库中1974 ~ 2024年间1564篇与肺泡再生相关的文献进行分析。使用VOSviewer(1.6.19版本)、CiteSpace(6.2版本)对数据进行可视化分析。R3)和biblioshiny R包。该分析涵盖了68个国家、1930个机构和658种期刊的9150名研究人员。美国以601篇论文和32172次引用领先,哈佛大学是最具影响力的机构。《美国呼吸与重症监护医学杂志》的影响因子最高(19.3),而《美国生理学杂志-肺细胞和分子生理学》的共被引次数最多(2,402)。爱德华·莫里西(Edward E. Morrisey)是最多产的作家,C. E. Barkauskas的共被引次数最多。关键词分析揭示了六大研究集群:干细胞与再生医学、急性肺损伤与纤维化、covid -19相关研究、慢性肺部疾病修复、细胞行为与分子机制、肺切除术后再生。主题映射表明,未来的研究应优先考虑肺损伤修复机制、组织再生中的基质环境、干细胞治疗和肺损伤修复中的免疫调节。结论本研究首次对肺泡再生进行了近50年的文献计量学分析,揭示了肺泡再生从基础机制探索到临床转化应用的进化趋势,为研究人员和资助机构提供了重要参考。
{"title":"Advancing the understanding of alveolar regeneration: Global research trends, thematic evolution, and emerging frontiers","authors":"Si-Cheng Zhou ,&nbsp;Ying-Xian Dong ,&nbsp;Jie Tian ,&nbsp;Guo-Wei Che ,&nbsp;Yutian Lai","doi":"10.1016/j.reth.2025.09.005","DOIUrl":"10.1016/j.reth.2025.09.005","url":null,"abstract":"<div><h3>Background</h3><div>Alveolar regeneration represents a critical research direction in respiratory disease treatment. Despite the surge in studies following the COVID-19 pandemic, comprehensive bibliometric analysis to systematically evaluate global research trends and future directions remains lacking<strong>.</strong></div></div><div><h3>Methods</h3><div>This study employed bibliometric methodology to analyze 1564 publications related to alveolar regeneration from 1974 to 2024 using the Web of Science Core Collection database. Data visualization and analysis were conducted using VOSviewer (version 1.6.19), CiteSpace (version 6.2.R3), and the biblioshiny R package.</div></div><div><h3>Results</h3><div>The analysis encompassed 68 countries, 1930 institutions, and 9150 researchers across 658 journals. The United States leads with 601 publications and 32,172 citations, with Harvard University as the most influential institution. The <em>American Journal of Respiratory and Critical Care Medicine</em> has the highest impact factor (19.3), while the <em>American Journal of Physiology-Lung Cellular and Molecular Physiology</em> has the most co-citations (2,402). Edward E. Morrisey is the most prolific author, and C. E. Barkauskas has the highest co-citations. Keyword analysis revealed six major research clusters: stem cells and regenerative medicine, acute lung injury and fibrosis, COVID-19-related research, chronic lung disease repair, cellular behavior and molecular mechanisms, and post-pneumonectomy regeneration. Thematic mapping indicates future research should prioritize lung injury repair mechanisms, matrix environment in tissue regeneration, stem cell therapeutics, and immune regulation in lung injury repair.</div></div><div><h3>Conclusion</h3><div>This first comprehensive 50-year bibliometric analysis of alveolar regeneration reveals the evolutionary trend from basic mechanistic exploration toward clinical translational applications, providing important reference for researchers and funding agencies.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 778-794"},"PeriodicalIF":3.5,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145219333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anastomotic leakage prevention using dry-preserved fibroblast cell sheets in esophageal reconstruction 干保存成纤维细胞片预防食管重建吻合口漏
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-09-30 DOI: 10.1016/j.reth.2025.09.011
Hiroshi Kurazumi , Ryunosuke Sakamoto , Koji Ueno , Akihiro Fujita , Kazumasa Matsunaga , Masashi Yanagihara , Yoshihiro Takemoto , Junichi Murakami , Atsunori Oga , Shunsaku Katsura , Kimikazu Hamano

Background

Anastomotic leakage is a common and serious complication of esophageal reconstruction, and new methods are required for its prevention in clinical settings. We herein developed dry-preserved fibroblast cell sheets (dry sheets), which are easy to use and promote wound healing. This study aimed to investigate the efficacy of transplanting allogeneic dry sheets in preventing anastomotic leakage in a rat esophageal reconstruction model.

Methods

Allogeneic dry sheets were prepared from the rat oral mucosa. A rat esophageal anastomosis model was created, and two dry sheets were applied to cover the anastomotic sites. Anastomotic leakage incidence, burst pressure, histological findings, and collagen contents were compared between the control and dry sheet groups postoperatively.

Results

The dry sheet group demonstrated a lower incidence of anastomotic leakage than the control group (control: 64 % vs. dry sheet: 28 % on day 3, control: 57 % vs. dry sheet: 29 % on day 5). Abscess scores at the esophageal anastomotic sites were also lower in the dry sheet group than in the control group on days 3 and 5. Burst pressure was significantly higher in the dry sheet group than in the control group on days 3 and 5. Collagen type I was significantly increased in the dry sheet group compared with that in the control group.

Conclusions

Allogeneic dry sheet application improved anastomotic leakage incidence and burst pressure, indicating the usefulness of these sheets in preventing esophageal anastomotic leakage.
背景食管吻合口瘘是食管重建术中常见且严重的并发症,临床上需要新的预防方法。我们在此开发了干燥保存的成纤维细胞片(干片),它易于使用并促进伤口愈合。本研究旨在探讨同种异体干片移植对大鼠食管重建模型吻合口漏的预防作用。方法以大鼠口腔黏膜为材料,制备致肉瘤干片。建立大鼠食管吻合模型,用两张干布覆盖吻合部位。比较对照组和干片组术后吻合口瘘发生率、破裂压力、组织学表现及胶原蛋白含量。结果干片组吻合口瘘发生率低于对照组(第3天,对照组64% vs.干片28%;第5天,对照组57% vs.干片29%)。第3、5天,干片组食管吻合口脓肿评分也低于对照组。第3天和第5天,干片组的破裂压力显著高于对照组。与对照组相比,干片组I型胶原蛋白含量显著增加。结论同种异体干片的应用降低了吻合口瘘发生率和破裂压力,说明干片在预防食管吻合口瘘中的作用。
{"title":"Anastomotic leakage prevention using dry-preserved fibroblast cell sheets in esophageal reconstruction","authors":"Hiroshi Kurazumi ,&nbsp;Ryunosuke Sakamoto ,&nbsp;Koji Ueno ,&nbsp;Akihiro Fujita ,&nbsp;Kazumasa Matsunaga ,&nbsp;Masashi Yanagihara ,&nbsp;Yoshihiro Takemoto ,&nbsp;Junichi Murakami ,&nbsp;Atsunori Oga ,&nbsp;Shunsaku Katsura ,&nbsp;Kimikazu Hamano","doi":"10.1016/j.reth.2025.09.011","DOIUrl":"10.1016/j.reth.2025.09.011","url":null,"abstract":"<div><h3>Background</h3><div>Anastomotic leakage is a common and serious complication of esophageal reconstruction, and new methods are required for its prevention in clinical settings. We herein developed dry-preserved fibroblast cell sheets (dry sheets), which are easy to use and promote wound healing. This study aimed to investigate the efficacy of transplanting allogeneic dry sheets in preventing anastomotic leakage in a rat esophageal reconstruction model.</div></div><div><h3>Methods</h3><div>Allogeneic dry sheets were prepared from the rat oral mucosa. A rat esophageal anastomosis model was created, and two dry sheets were applied to cover the anastomotic sites. Anastomotic leakage incidence, burst pressure, histological findings, and collagen contents were compared between the control and dry sheet groups postoperatively.</div></div><div><h3>Results</h3><div>The dry sheet group demonstrated a lower incidence of anastomotic leakage than the control group (control: 64 % vs. dry sheet: 28 % on day 3, control: 57 % vs. dry sheet: 29 % on day 5). Abscess scores at the esophageal anastomotic sites were also lower in the dry sheet group than in the control group on days 3 and 5. Burst pressure was significantly higher in the dry sheet group than in the control group on days 3 and 5. Collagen type I was significantly increased in the dry sheet group compared with that in the control group.</div></div><div><h3>Conclusions</h3><div>Allogeneic dry sheet application improved anastomotic leakage incidence and burst pressure, indicating the usefulness of these sheets in preventing esophageal anastomotic leakage.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 795-801"},"PeriodicalIF":3.5,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145219329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cholangiocyte-derived exosomal miR-381-3p promotes hepatic stellate cell activation and cholestatic liver fibrosis via targeting Klf6 胆管细胞来源的外泌体miR-381-3p通过靶向Klf6促进肝星状细胞活化和胆汁淤积性肝纤维化
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-09-26 DOI: 10.1016/j.reth.2025.09.008
Yang Gao, Yonglin Chen, Yuanyi Mang, Xibing Zhang, Xiaoshan Li, Shengning Zhang

Introduction

The activation of hepatic stellate cells (HSCs) is a central mechanism driving the progression of chronic cholestatic liver diseases (CCLD). MicroRNAs (miRNAs) have been increasingly recognized for their regulatory roles in various liver pathologies. This study aimed to identify specific miRNAs involved in the progression of CCLD and elucidate their underlying molecular mechanisms.

Methods

A bile duct ligation (BDL) mouse model was established to mimic cholestatic liver injury. Exosomes were isolated from mouse large cholangiocytes (MLE) and co-cultured with HSCs to investigate their functional effects. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was employed to assess the expression levels of fibrotic marker genes. Exosomal miRNA microarray assay was used to screen differentially expressed miRNAs. Furthermore, dual-luciferase reporter assays and RNA pull-down experiments were conducted to validate the interaction between miR-381-3p and its putative target gene, kinesin family member 6 (Klf6).

Results

The results confirmed the successful isolation of exosomes from MLE. Furthermore, exosomes derived from BDL-MLE were shown to promote the activation of HSCs and exacerbate hepatic fibrosis. Dicer knockout reduced the mRNA expression of key fibrotic markers. In addition, miR-381-3p was found to be upregulated both in BDL-MLE–derived exosomes and in HSCs treated with transforming growth factor (TGF)-β and BDL-MLE–exosomes. Mechanistic investigations identified Klf6 as a direct target gene of miR-381-3p. Rescue experiments further revealed that overexpression of Klf6 alleviated the pro-fibrotic effects caused by miR-381-3p overexpression, thereby attenuating HSC activation and mitigating cholestatic liver fibrosis.

Conclusion

This study highlighted the role of MLE-derived exosomal miR-381-3p in promoting HSC activation and cholestatic liver fibrosis through the regulation of Klf6. These findings provide novel insights into the molecular mechanisms underlying CCLD.
肝星状细胞(hsc)的激活是推动慢性胆汁淤积性肝病(CCLD)进展的中心机制。MicroRNAs (miRNAs)在各种肝脏病理中的调节作用越来越得到人们的认可。本研究旨在鉴定参与CCLD进展的特异性mirna并阐明其潜在的分子机制。方法建立模拟胆汁淤积性肝损伤的小鼠胆管结扎模型。从小鼠大胆管细胞(MLE)中分离外泌体,并与造血干细胞共培养,研究其功能作用。采用逆转录定量聚合酶链反应(RT-qPCR)检测纤维化标记基因的表达水平。外泌体miRNA微阵列法筛选差异表达的miRNA。此外,我们进行了双荧光素酶报告基因检测和RNA下拉实验来验证miR-381-3p与其假定的靶基因——激酶蛋白家族成员6 (Klf6)之间的相互作用。结果成功分离了MLE外泌体。此外,BDL-MLE衍生的外泌体被证明可以促进hsc的激活并加剧肝纤维化。Dicer敲除降低了关键纤维化标志物的mRNA表达。此外,miR-381-3p在bdl - mle衍生的外泌体和转化生长因子(TGF)-β和bdl - mle外泌体处理的造血干细胞中均被发现上调。机制研究发现Klf6是miR-381-3p的直接靶基因。救援实验进一步发现,Klf6过表达可减轻miR-381-3p过表达引起的促纤维化作用,从而减弱HSC活化,减轻胆汁淤积性肝纤维化。结论本研究强调了mle来源的外泌体miR-381-3p通过调控Klf6促进HSC活化和胆汁淤积性肝纤维化的作用。这些发现为CCLD的分子机制提供了新的见解。
{"title":"Cholangiocyte-derived exosomal miR-381-3p promotes hepatic stellate cell activation and cholestatic liver fibrosis via targeting Klf6","authors":"Yang Gao,&nbsp;Yonglin Chen,&nbsp;Yuanyi Mang,&nbsp;Xibing Zhang,&nbsp;Xiaoshan Li,&nbsp;Shengning Zhang","doi":"10.1016/j.reth.2025.09.008","DOIUrl":"10.1016/j.reth.2025.09.008","url":null,"abstract":"<div><h3>Introduction</h3><div>The activation of hepatic stellate cells (HSCs) is a central mechanism driving the progression of chronic cholestatic liver diseases (CCLD). MicroRNAs (miRNAs) have been increasingly recognized for their regulatory roles in various liver pathologies. This study aimed to identify specific miRNAs involved in the progression of CCLD and elucidate their underlying molecular mechanisms.</div></div><div><h3>Methods</h3><div>A bile duct ligation (BDL) mouse model was established to mimic cholestatic liver injury. Exosomes were isolated from mouse large cholangiocytes (MLE) and co-cultured with HSCs to investigate their functional effects. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was employed to assess the expression levels of fibrotic marker genes. Exosomal miRNA microarray assay was used to screen differentially expressed miRNAs. Furthermore, dual-luciferase reporter assays and RNA pull-down experiments were conducted to validate the interaction between miR-381-3p and its putative target gene, kinesin family member 6 (Klf6).</div></div><div><h3>Results</h3><div>The results confirmed the successful isolation of exosomes from MLE. Furthermore, exosomes derived from BDL-MLE were shown to promote the activation of HSCs and exacerbate hepatic fibrosis. Dicer knockout reduced the mRNA expression of key fibrotic markers. In addition, miR-381-3p was found to be upregulated both in BDL-MLE–derived exosomes and in HSCs treated with transforming growth factor (TGF)-β and BDL-MLE–exosomes. Mechanistic investigations identified Klf6 as a direct target gene of miR-381-3p. Rescue experiments further revealed that overexpression of Klf6 alleviated the pro-fibrotic effects caused by miR-381-3p overexpression, thereby attenuating HSC activation and mitigating cholestatic liver fibrosis.</div></div><div><h3>Conclusion</h3><div>This study highlighted the role of MLE-derived exosomal miR-381-3p in promoting HSC activation and cholestatic liver fibrosis through the regulation of Klf6. These findings provide novel insights into the molecular mechanisms underlying CCLD.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 769-777"},"PeriodicalIF":3.5,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145157155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimized personnel flow with minimal contamination: development and validation of an air-barrier cleanroom for cell products processing 以最小的污染优化人员流动:开发和验证用于细胞产品处理的空气屏障洁净室
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-09-18 DOI: 10.1016/j.reth.2025.09.001
Mitsuru Mizuno , Hideaki Tani , Kaori Nomura , Daijiro Sone , Kentaro Amano , Gen Tominaga , Yuki Chiba , Ichiro Sekiya

Introduction

Cell processing facilities for regenerative medicine require strict prevention of cross-contamination. However, the typically employed sealed, multi-room layout increases energy demands and capital costs due to heating, ventilation, and air-conditioning (HVAC), and restricts staff mobility. We devised a semi-open (SO) cleanroom that eliminated doors between the cell processing room (CPR) and adjoining corridor, while maintaining unidirectional airflow as a barrier. This study rigorously compared four interface variants—plain opening, wing walls, push–pull ventilation, and a conventional swing door—to verify whether operational flexibility can be achieved without compromising particle content performance at the CPR–corridor interface.

Methods

Computational fluid dynamics (CFD) simulations reproduced two connected rooms separated by a 900 × 2000-mm2 opening, supplied at 23 m3/min (35 air changes per hour) constantly. Four interfaces were evaluated: plain opening, 100–500 mm wing-wall panels, push–pull ventilation adjusted to a 0.75 ratio, and a conventional swing door. A 1-m/s cross-draft emulated personnel transit. Identical full-scale mock-ups were built; particle image velocimetry (PIV) quantified airflow vectors, and optical counters logged 0.5-μm aerosols during 5-min exit and entry. The primary endpoints were the inflow particle concentration ratio across the opening and the cumulative adjacent-room transfer proportions.

Results

CFD showed all layouts leaked ≤0.011 %, with a 1 m/s walking draft, push–pull kept inflow below 0.05 %, halving 500-mm wing-wall performance and outperforming plain openings. The PIV confirmed significant differences in airflow velocity distributions under each condition in the case of the exit. The semi-open layout without doors showed a lower proportion of vectors pointing opposite to the forward direction than the conventional layout in both the exit and entry cases. Particle counts supported this: push–pull transferred 0.013 % of particles on exit, 32.8 % on entry, giving overall migration to the adjacent room of 0.0043 %.

Conclusions

The SO cleanroom concept suppresses fluctuations in particle content at the CPR–corridor interface while eliminating physical doors, enabling flexible personnel flow and obviating extra HVAC zones. Push–pull ventilation delivered the most robust containment against walking-induced disturbances, whereas the 500-mm wing walls offered a passive, power-free alternative with moderate protection. With worst-case inter-room transfers below 0.05 %, SO designs can rationally replace conventional door-sealed rooms, substantially reducing energy and construction costs in regenerative medicine manufacturing.
再生医学的细胞处理设施需要严格防止交叉污染。然而,由于采暖、通风和空调(HVAC),通常采用密封的多房间布局增加了能源需求和资本成本,并限制了员工的流动性。我们设计了一个半开放式(SO)洁净室,消除了细胞处理室(CPR)和相邻走廊之间的门,同时保持单向气流作为屏障。本研究严格比较了四种不同的界面——平开口、翼墙、推拉式通风和传统的旋转门,以验证在不影响cpr -走廊界面颗粒含量性能的情况下,是否可以实现操作灵活性。方法计算流体力学(CFD)模拟再现了两个相连的房间,由一个900 × 2000-mm2的开口隔开,以23 m3/min(每小时换气35次)的速度连续供气。评估了四个界面:普通开口,100-500毫米翼墙面板,推拉通风调节到0.75比率,以及传统的旋转门。1米/秒的交叉通风模拟人员运输。制作了完全相同的全尺寸模型;粒子图像测速(PIV)量化了气流矢量,光学计数器记录了0.5 μm气溶胶在5分钟内的进出情况。主要终点是入口颗粒浓度比和累积的相邻室转移比。结果scfd显示,所有布局漏损≤0.011%,行走吃水1 m/s,推挽流保持在0.05%以下,500 mm翼壁性能降低一半,优于普通开孔。PIV证实,在出口情况下,各工况下的气流速度分布存在显著差异。在出入口两种情况下,无门的半开放式布局中指向前方相反方向的矢量所占比例均低于常规布局。粒子计数支持这一点:推拉在出口转移了0.013%的粒子,在入口转移了32.8%,总体迁移到相邻房间的比例为0.0043%。SO洁净室概念抑制了cpr -走廊界面颗粒含量的波动,同时消除了物理门,实现了灵活的人员流动,避免了额外的暖通空调区域。推挽式通风系统对行走引起的干扰提供了最强大的遏制,而500毫米的翼墙则提供了一种被动的、无动力的替代方案,具有适度的保护作用。SO设计可合理替代传统的闭门房间,在最坏情况下房间间传输量低于0.05%,大大降低再生医药制造的能源和建筑成本。
{"title":"Optimized personnel flow with minimal contamination: development and validation of an air-barrier cleanroom for cell products processing","authors":"Mitsuru Mizuno ,&nbsp;Hideaki Tani ,&nbsp;Kaori Nomura ,&nbsp;Daijiro Sone ,&nbsp;Kentaro Amano ,&nbsp;Gen Tominaga ,&nbsp;Yuki Chiba ,&nbsp;Ichiro Sekiya","doi":"10.1016/j.reth.2025.09.001","DOIUrl":"10.1016/j.reth.2025.09.001","url":null,"abstract":"<div><h3>Introduction</h3><div>Cell processing facilities for regenerative medicine require strict prevention of cross-contamination. However, the typically employed sealed, multi-room layout increases energy demands and capital costs due to heating, ventilation, and air-conditioning (HVAC), and restricts staff mobility. We devised a semi-open (SO) cleanroom that eliminated doors between the cell processing room (CPR) and adjoining corridor, while maintaining unidirectional airflow as a barrier. This study rigorously compared four interface variants—plain opening, wing walls, push–pull ventilation, and a conventional swing door—to verify whether operational flexibility can be achieved without compromising particle content performance at the CPR–corridor interface.</div></div><div><h3>Methods</h3><div>Computational fluid dynamics (CFD) simulations reproduced two connected rooms separated by a 900 × 2000-mm<sup>2</sup> opening, supplied at 23 m<sup>3</sup>/min (35 air changes per hour) constantly. Four interfaces were evaluated: plain opening, 100–500 mm wing-wall panels, push–pull ventilation adjusted to a 0.75 ratio, and a conventional swing door. A 1-m/s cross-draft emulated personnel transit. Identical full-scale mock-ups were built; particle image velocimetry (PIV) quantified airflow vectors, and optical counters logged 0.5-μm aerosols during 5-min exit and entry. The primary endpoints were the inflow particle concentration ratio across the opening and the cumulative adjacent-room transfer proportions.</div></div><div><h3>Results</h3><div>CFD showed all layouts leaked ≤0.011 %, with a 1 m/s walking draft, push–pull kept inflow below 0.05 %, halving 500-mm wing-wall performance and outperforming plain openings. The PIV confirmed significant differences in airflow velocity distributions under each condition in the case of the exit. The semi-open layout without doors showed a lower proportion of vectors pointing opposite to the forward direction than the conventional layout in both the exit and entry cases. Particle counts supported this: push–pull transferred 0.013 % of particles on exit, 32.8 % on entry, giving overall migration to the adjacent room of 0.0043 %.</div></div><div><h3>Conclusions</h3><div>The SO cleanroom concept suppresses fluctuations in particle content at the CPR–corridor interface while eliminating physical doors, enabling flexible personnel flow and obviating extra HVAC zones. Push–pull ventilation delivered the most robust containment against walking-induced disturbances, whereas the 500-mm wing walls offered a passive, power-free alternative with moderate protection. With worst-case inter-room transfers below 0.05 %, SO designs can rationally replace conventional door-sealed rooms, substantially reducing energy and construction costs in regenerative medicine manufacturing.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 760-768"},"PeriodicalIF":3.5,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145094918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recombinant production of canine vitronectin for optimizing the culture of canine induced pluripotent stem cells 重组犬玻璃体连接蛋白优化犬诱导多能干细胞培养
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-09-16 DOI: 10.1016/j.reth.2025.09.002
Kohei Shishida , Yui Ikuta , Hiroko Sugisaki , Kazuto Kimura , Jun Katahira , Masaya Tsukamoto , Shingo Hatoya

Introduction

Canine induced pluripotent stem cells (ciPSCs) have attracted attention as valuable tools in veterinary regenerative medicine and disease modeling. Feeder-free culture of ciPSCs using iMatrix-511 has become feasible. Since the choice of extracellular matrix (ECM) has been shown to significantly affect not only the maintenance of pluripotency but also the efficiency of directed differentiation, systematic evaluation of multiple ECM substrates is considered important in ciPSC culture as well. Furthermore, considering future clinical applications, it is essential to establish a xeno-free culture system. Vitronectin (VTN) is a protein that can be easily expressed as a recombinant product in Escherichia coli, making it suitable for scalable ECM production. In this study, we generated recombinant canine-derived VTN and evaluated its effects on ciPSCs in comparison with human-derived ECM substrates.

Methods

In this study, we generated recombinant full-length and N-terminally truncated forms of canine vitronectin (cVTN and cVTN-N) using a bacterial expression system. These substrates, along with established human-derived ECM proteins including iMatrix-511, hVTN, and hVTN-N, were evaluated for their ability to support ciPSC adhesion, proliferation, and the maintenance of pluripotency and differentiation potential. Pluripotency and differentiation capacity were assessed using immunostaining and gene expression analysis.

Results

Both cVTN and cVTN-N demonstrated support for ciPSC attachment and long-term proliferation at levels comparable to those of human-derived ECM substrates. ciPSCs cultured on cVTN or cVTN-N maintained high expression levels of pluripotency markers; in particular, cVTN significantly enhanced SOX2 expression, while cVTN-N was associated with reduced mesodermal marker expression. Efficient EBs formation and trilineage differentiation were achieved on all tested substrates, with only minor differences in lineage marker expression among groups.

Conclusions

Recombinant canine-derived VTN were shown to function as an effective, species-matched substrate for ciPSC culture, exhibiting comparable performance to human-derived ECM proteins. These results suggest that canine-derived VTN enables stable proliferation and maintenance of pluripotency in ciPSCs, providing a promising platform for future research in canine regenerative medicine.
犬诱导多能干细胞(ciPSCs)作为兽医再生医学和疾病建模的重要工具而备受关注。使用iMatrix-511对ciPSCs进行无饲养培养已经成为可能。由于细胞外基质(ECM)的选择不仅会显著影响多能性的维持,还会影响定向分化的效率,因此对多种ECM底物的系统评估在ciPSC培养中也被认为是重要的。此外,考虑到未来的临床应用,建立无异种培养体系是必要的。Vitronectin (VTN)是一种易于在大肠杆菌中表达的重组蛋白,适用于规模化ECM生产。在这项研究中,我们生成了重组犬源性VTN,并与人源性ECM底物比较,评估了其对ciPSCs的影响。方法利用细菌表达系统,构建了犬玻璃体连接蛋白(cVTN和cVTN- n)的全长和n端截短重组蛋白。这些底物,连同已建立的人源ECM蛋白,包括iMatrix-511、hVTN和hVTN- n,被评估其支持ciPSC粘附、增殖、维持多能性和分化潜力的能力。通过免疫染色和基因表达分析评估多能性和分化能力。结果cVTN和cVTN- n均显示支持ciPSC附着和长期增殖,其水平与人源ECM底物相当。在cVTN或cVTN- n上培养的ciPSCs保持了高水平的多能性标志物的表达;其中,cVTN显著增强SOX2表达,而cVTN- n与中胚层标志物表达降低相关。在所有测试的底物上都实现了高效的EBs形成和三龄分化,各组间谱系标记的表达只有微小差异。结论重组犬源性VTN是一种有效的、物种匹配的ciPSC培养底物,表现出与人源性ECM蛋白相当的性能。这些结果表明,犬源性VTN能够在ciPSCs中稳定增殖并维持多能性,为犬再生医学的未来研究提供了一个有希望的平台。
{"title":"Recombinant production of canine vitronectin for optimizing the culture of canine induced pluripotent stem cells","authors":"Kohei Shishida ,&nbsp;Yui Ikuta ,&nbsp;Hiroko Sugisaki ,&nbsp;Kazuto Kimura ,&nbsp;Jun Katahira ,&nbsp;Masaya Tsukamoto ,&nbsp;Shingo Hatoya","doi":"10.1016/j.reth.2025.09.002","DOIUrl":"10.1016/j.reth.2025.09.002","url":null,"abstract":"<div><h3>Introduction</h3><div>Canine induced pluripotent stem cells (ciPSCs) have attracted attention as valuable tools in veterinary regenerative medicine and disease modeling. Feeder-free culture of ciPSCs using iMatrix-511 has become feasible. Since the choice of extracellular matrix (ECM) has been shown to significantly affect not only the maintenance of pluripotency but also the efficiency of directed differentiation, systematic evaluation of multiple ECM substrates is considered important in ciPSC culture as well. Furthermore, considering future clinical applications, it is essential to establish a xeno-free culture system. Vitronectin (VTN) is a protein that can be easily expressed as a recombinant product in <em>Escherichia coli</em>, making it suitable for scalable ECM production. In this study, we generated recombinant canine-derived VTN and evaluated its effects on ciPSCs in comparison with human-derived ECM substrates.</div></div><div><h3>Methods</h3><div>In this study, we generated recombinant full-length and N-terminally truncated forms of canine vitronectin (cVTN and cVTN-N) using a bacterial expression system. These substrates, along with established human-derived ECM proteins including iMatrix-511, hVTN, and hVTN-N, were evaluated for their ability to support ciPSC adhesion, proliferation, and the maintenance of pluripotency and differentiation potential. Pluripotency and differentiation capacity were assessed using immunostaining and gene expression analysis.</div></div><div><h3>Results</h3><div>Both cVTN and cVTN-N demonstrated support for ciPSC attachment and long-term proliferation at levels comparable to those of human-derived ECM substrates. ciPSCs cultured on cVTN or cVTN-N maintained high expression levels of pluripotency markers; in particular, cVTN significantly enhanced SOX2 expression, while cVTN-N was associated with reduced mesodermal marker expression. Efficient EBs formation and trilineage differentiation were achieved on all tested substrates, with only minor differences in lineage marker expression among groups.</div></div><div><h3>Conclusions</h3><div>Recombinant canine-derived VTN were shown to function as an effective, species-matched substrate for ciPSC culture, exhibiting comparable performance to human-derived ECM proteins. These results suggest that canine-derived VTN enables stable proliferation and maintenance of pluripotency in ciPSCs, providing a promising platform for future research in canine regenerative medicine.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 751-759"},"PeriodicalIF":3.5,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145094919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional analysis of human induced pluripotent stem cell-derived cardiac tissue during endothelial cell network changes 内皮细胞网络变化过程中人诱导多能干细胞衍生心脏组织的功能分析
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-09-10 DOI: 10.1016/j.reth.2025.08.015
Toshiharu Koike , Katsuhisa Matsuura , Shinako Masuda , Takuma Takada , Tatsuro Iida , Tatsuya Shimizu , Junichi Yamaguchi

Introduction

Tissue structure stability is essential for effective contractile function in cardiac tissue. Although endothelial cells (ECs) serve as critical sources for functional bioengineered cardiac tissue, the process of network changes in ECs affects the cardiac tissue structure. However, how the process precisely influences the synchrony of cardiomyocytes (CMs) contraction and the contraction regularity in the cardiac tissue remains unclear.

Methods

Human induced pluripotent stem cell-derived CMs (hiPSC-CMs) were cultured in well-plates for 9–10 days until they displayed stable spontaneous beating. Human umbilical vein endothelial cells (HUVECs) and normal human dermal fibroblasts (NHDFs), or NHDFs alone, were then seeded and cultured with hiPSC-CMs for 3 days (NHDF + HUVEC + CM, NHDF + CM). Changes in the EC network and cardiac functionality were analyzed over the 3-day period following seeding.

Results

The EC network expanded until day 2, after which it stabilized. The EC network was observed at the layer of hiPSC-CMs on day 3 in NHDF + HUVEC + CM cultures. Motion capture analysis revealed that hiPSC-CMs in NHDF + HUVEC + CM exhibited more synchronous contractions on day 2 than those in NHDF + CM, with no notable differences on days 1 and 3. The irregularity of spontaneous beat rates, measured using cardiac calcium imaging, was significantly higher in NHDF + HUVEC + CM than in NHDF + CM on day 1. However, the irregularity of spontaneous beating in NHDF + HUVEC + CM was more stabilized on day 3 compared with day1. Other parameters, including contraction amplitude, spontaneous beat rate, and calcium uptake and release, did not significantly differ between NHDF + HUVEC + CM and NHDF + CM over time.

Conclusions

Alterations in the EC network may induce irregular spontaneous contractions in hiPSC-CMs at the early phase of co-culture followed by more regular contractions over time, with improving synchrony in the contractions within the cardiac tissue transiently.
组织结构的稳定性对心脏组织的有效收缩功能至关重要。尽管内皮细胞(ECs)是功能性生物工程心脏组织的重要来源,但内皮细胞网络变化的过程会影响心脏组织结构。然而,该过程如何精确影响心肌细胞(CMs)收缩的同时性和心脏组织的收缩规律尚不清楚。方法人诱导多能干细胞来源的CMs (hiPSC-CMs)在孔板中培养9-10天,使其表现出稳定的自发跳动。然后将人脐静脉内皮细胞(HUVECs)和正常人真皮成纤维细胞(NHDFs)或单独的NHDFs与hiPSC-CMs (NHDF + HUVEC + CM, NHDF + CM)一起接种并培养3天。在播种后的3天内分析EC网络和心脏功能的变化。结果EC网络扩展至第2天,之后趋于稳定。NHDF + HUVEC + CM培养第3天,在hiPSC-CMs层观察到EC网络。运动捕捉分析显示,NHDF + HUVEC + CM的hiPSC-CMs在第2天比NHDF + CM的hiPSC-CMs同步收缩更多,第1天和第3天差异不显著。在第1天,通过心脏钙显像测量的自发心率不规则性,NHDF + HUVEC + CM组明显高于NHDF + CM组。而NHDF + HUVEC + CM自发性心律失常在第3天较第1天更加稳定。NHDF + HUVEC + CM和NHDF + CM之间的其他参数,包括收缩幅度、自发心率、钙摄取和释放,随时间的推移没有显著差异。结论EC网络的改变可能在共培养早期诱导hiPSC-CMs不规则的自发收缩,随着时间的推移收缩更加规律,心脏组织内收缩的同步性暂时改善。
{"title":"Functional analysis of human induced pluripotent stem cell-derived cardiac tissue during endothelial cell network changes","authors":"Toshiharu Koike ,&nbsp;Katsuhisa Matsuura ,&nbsp;Shinako Masuda ,&nbsp;Takuma Takada ,&nbsp;Tatsuro Iida ,&nbsp;Tatsuya Shimizu ,&nbsp;Junichi Yamaguchi","doi":"10.1016/j.reth.2025.08.015","DOIUrl":"10.1016/j.reth.2025.08.015","url":null,"abstract":"<div><h3>Introduction</h3><div>Tissue structure stability is essential for effective contractile function in cardiac tissue. Although endothelial cells (ECs) serve as critical sources for functional bioengineered cardiac tissue, the process of network changes in ECs affects the cardiac tissue structure. However, how the process precisely influences the synchrony of cardiomyocytes (CMs) contraction and the contraction regularity in the cardiac tissue remains unclear.</div></div><div><h3>Methods</h3><div>Human induced pluripotent stem cell-derived CMs (hiPSC-CMs) were cultured in well-plates for 9–10 days until they displayed stable spontaneous beating. Human umbilical vein endothelial cells (HUVECs) and normal human dermal fibroblasts (NHDFs), or NHDFs alone, were then seeded and cultured with hiPSC-CMs for 3 days (NHDF + HUVEC + CM, NHDF + CM). Changes in the EC network and cardiac functionality were analyzed over the 3-day period following seeding.</div></div><div><h3>Results</h3><div>The EC network expanded until day 2, after which it stabilized. The EC network was observed at the layer of hiPSC-CMs on day 3 in NHDF + HUVEC + CM cultures. Motion capture analysis revealed that hiPSC-CMs in NHDF + HUVEC + CM exhibited more synchronous contractions on day 2 than those in NHDF + CM, with no notable differences on days 1 and 3. The irregularity of spontaneous beat rates, measured using cardiac calcium imaging, was significantly higher in NHDF + HUVEC + CM than in NHDF + CM on day 1. However, the irregularity of spontaneous beating in NHDF + HUVEC + CM was more stabilized on day 3 compared with day1. Other parameters, including contraction amplitude, spontaneous beat rate, and calcium uptake and release, did not significantly differ between NHDF + HUVEC + CM and NHDF + CM over time.</div></div><div><h3>Conclusions</h3><div>Alterations in the EC network may induce irregular spontaneous contractions in hiPSC-CMs at the early phase of co-culture followed by more regular contractions over time, with improving synchrony in the contractions within the cardiac tissue transiently.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 740-750"},"PeriodicalIF":3.5,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145044360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ex vivo expansion of corneal endothelial cells enabled by small molecule inhibitors of LATS kinase LATS激酶小分子抑制剂使角膜内皮细胞体外扩增
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-09-03 DOI: 10.1016/j.reth.2025.08.014
Natsuki Abe-Fukasawa , Ryuhei Hayashi , Mio Morita , Shohei Azuma , Takumi Iwawaki , Kenta Kagaya , Taito Nishino , Kohji Nishida

Introduction

Transplantation of expanded corneal endothelial cells (CECs) has been regarded as a promising approach for treating corneal diseases caused by CEC damage or dysfunction. However, an efficient method for expanding CECs remains inadequately established.

Methods

We examined whether small molecule inhibitors of large tumor suppressor kinase (LATS) promote the proliferation of CECs. We also evaluated the expression of functional markers in CECs treated with the inhibitors.

Results

We found that LATS kinase inhibitors enhance the cell density of bovine CECs ex vivo. CECs that were expanded in the presence of these inhibitors exhibited increased nuclear translocation of yes-associated protein (YAP) and upregulated expression of YAP-regulated genes. Furthermore, we observed that YAP was essential for promoting cell proliferation. Notably, the inhibitors also increased the density of primary human CECs. Expanded human CECs expressed CEC functional markers, including Na+/K+-transporting ATPase subunit alpha-1 (ATP1A1), Zonula occludens-1 (ZO-1), and N-cadherin; they showed upregulated expression of YAP-regulated genes.

Conclusions

Collectively, these findings support the development of efficient culture techniques for CEC expansion and may facilitate the advancement of therapeutic strategies for CEC-associated diseases.
扩大的角膜内皮细胞(CECs)移植被认为是治疗由CEC损伤或功能障碍引起的角膜疾病的一种很有前途的方法。然而,扩大cec的有效方法仍未充分确立。方法观察大肿瘤抑制激酶(large tumor suppressor kinase, LATS)小分子抑制剂是否促进CECs增殖。我们还评估了用抑制剂治疗的CECs中功能标志物的表达。结果LATS激酶抑制剂可提高体外牛CECs细胞密度。在这些抑制剂存在的情况下,cec的扩增表现出yes相关蛋白(YAP)的核易位增加和YAP调控基因的表达上调。此外,我们观察到YAP对促进细胞增殖至关重要。值得注意的是,抑制剂也增加了原发人CECs的密度。扩增的人CEC表达CEC功能标记物,包括Na+/K+转运atp酶亚基α -1 (ATP1A1)、封闭带-1 (ZO-1)和n -钙粘蛋白;它们表现出yap调控基因的上调表达。综上所述,这些发现支持了CEC扩展的高效培养技术的发展,并可能促进CEC相关疾病的治疗策略的发展。
{"title":"Ex vivo expansion of corneal endothelial cells enabled by small molecule inhibitors of LATS kinase","authors":"Natsuki Abe-Fukasawa ,&nbsp;Ryuhei Hayashi ,&nbsp;Mio Morita ,&nbsp;Shohei Azuma ,&nbsp;Takumi Iwawaki ,&nbsp;Kenta Kagaya ,&nbsp;Taito Nishino ,&nbsp;Kohji Nishida","doi":"10.1016/j.reth.2025.08.014","DOIUrl":"10.1016/j.reth.2025.08.014","url":null,"abstract":"<div><h3>Introduction</h3><div>Transplantation of expanded corneal endothelial cells (CECs) has been regarded as a promising approach for treating corneal diseases caused by CEC damage or dysfunction. However, an efficient method for expanding CECs remains inadequately established.</div></div><div><h3>Methods</h3><div>We examined whether small molecule inhibitors of large tumor suppressor kinase (LATS) promote the proliferation of CECs. We also evaluated the expression of functional markers in CECs treated with the inhibitors.</div></div><div><h3>Results</h3><div>We found that LATS kinase inhibitors enhance the cell density of bovine CECs <em>ex vivo</em>. CECs that were expanded in the presence of these inhibitors exhibited increased nuclear translocation of yes-associated protein (YAP) and upregulated expression of YAP-regulated genes. Furthermore, we observed that YAP was essential for promoting cell proliferation. Notably, the inhibitors also increased the density of primary human CECs. Expanded human CECs expressed CEC functional markers, including Na<sup>+</sup>/K<sup>+</sup>-transporting ATPase subunit alpha-1 (ATP1A1), Zonula occludens-1 (ZO-1), and N-cadherin; they showed upregulated expression of YAP-regulated genes.</div></div><div><h3>Conclusions</h3><div>Collectively, these findings support the development of efficient culture techniques for CEC expansion and may facilitate the advancement of therapeutic strategies for CEC-associated diseases.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 730-739"},"PeriodicalIF":3.5,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144932122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cisplatin-induced acute kidney injury is alleviated by BMSCs-derived exosome via mmu-miR-874-3p-mediated activation of the wnt/β-catenin signaling pathway 通过mmu- mir -874-3p介导的wnt/β-catenin信号通路激活,bmscs来源的外泌体减轻了顺铂诱导的急性肾损伤
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-09-01 DOI: 10.1016/j.reth.2025.08.016
Deyang Kong , Zhuohang Yang , Xiaoting Zhang , Yifan Song , Umer Anayyat , Yanping Li , Hao Liu , Zhanci Ou , Shuo Pang , Xiaomei Wang

Background

Acute kidney injury (AKI) results from cisplatin chemotherapeutic agents in 30 %–46 % of patients, but clinically effective preventive and therapeutic approaches are lacking. Bone marrow mesenchymal stem cells-derived exosomes (BMSCs-exo) have potential in tissue repair, but the mechanism by which they attenuate cisplatin-induced kidney injury is unknown.

Objective

To explore the therapeutic effect of BMSCs-exo on cisplatin-induced AKI and to analyze the key molecular mechanism involved.

Methods and materials

BMSCs-exo were extracted via ultracentrifugation and identified via transmission electron microscopy, nanoparticle analysis and Western blot. C57BL/6 mice were divided into a control group (Con), a cisplatin model group (Cis), and a BMSCs-exo treatment group (BMSCs-exo), and renal function was dynamically tested. PAS staining was used to observe histopathological changes in mouse kidney tissues, while immunohistochemistry was employed to assess the expression levels of Wnt4, β-catenin, FZD5, CD31, and the tubular injury markers NGAL and KIM1. Western blot was used to detect the expression of Wnt4, β-catenin, FZD5 and CD31. High-throughput sequencing was used to screen for differential miRNAs, and GO/KEGG enrichment analysis of target genes was performed.

Results

Blood creatinine and urea nitrogen levels were significantly higher in the Cis group than in the Con group, and renal tubular epithelial cells exhibited necrosis, confirming successful AKI model establishment. BMSCs-exo alleviated renal dysfunction, histopathological alterations, and tubular injury in vivo, as evidenced by NGAL and KIM1 expression. We further demonstrated that BMSCs-exo specifically localized to the injured kidney. MiRNA sequencing of renal tissues from the Con, Cis and BMSCs-exo groups identified mmu-miR-874-3p—enriched in Wnt signaling and angiogenesis pathways—as a key mediator of the renoprotective effects of BMSCs-exo, with FZD5 as its downstream target. Moreover, treatment with BMSCs-exo markedly prevented microvascular loss. In the BMSCs-exo group, Wnt4, β-catenin and CD31 expression were upregulated, whereas FZD5 expression was downregulated, consistent with the immunohistochemistry results.

Conclusions

BMSCs-exo protect kidneys against cisplatin-induced AKI(Cis-AKI) by attenuating injury to the renal microvasculature and tubule epithelial cells, primarily through mmu-miR-874-3p-mediated inhibition of FZD5 activation and promotion of Wnt/β-catenin pathway activation.
急性肾损伤(AKI)在30% - 46%的患者中由顺铂化疗药物引起,但缺乏临床有效的预防和治疗方法。骨髓间充质干细胞衍生的外泌体(BMSCs-exo)在组织修复中具有潜力,但其减轻顺铂诱导的肾损伤的机制尚不清楚。目的探讨骨髓间充质干细胞外显子(BMSCs-exo)对顺铂性AKI的治疗作用,并分析其关键分子机制。方法和材料采用超离心提取bmscs -exo,并通过透射电镜、纳米颗粒分析和Western blot对其进行鉴定。将C57BL/6小鼠分为对照组(Con)、顺铂模型组(Cis)和BMSCs-exo治疗组(BMSCs-exo),动态检测肾功能。PAS染色观察小鼠肾组织病理变化,免疫组化检测Wnt4、β-catenin、FZD5、CD31及肾小管损伤标志物NGAL、KIM1的表达水平。Western blot检测Wnt4、β-catenin、FZD5、CD31的表达。采用高通量测序筛选差异mirna,并对靶基因进行GO/KEGG富集分析。结果Cis组大鼠血肌酐、尿素氮水平明显高于Con组,肾小管上皮细胞出现坏死,证实AKI模型建立成功。通过NGAL和KIM1的表达证实,BMSCs-exo减轻了体内肾功能障碍、组织病理学改变和肾小管损伤。我们进一步证明BMSCs-exo特异性定位于受损肾脏。Con、Cis和BMSCs-exo组肾组织的MiRNA测序发现,富含Wnt信号通路和血管生成途径的mmu- mir -874- 3d - p是BMSCs-exo的肾保护作用的关键介质,FZD5是其下游靶点。此外,BMSCs-exo治疗可显著防止微血管丢失。在BMSCs-exo组中,Wnt4、β-catenin和CD31表达上调,而FZD5表达下调,与免疫组化结果一致。结论bmscs -exo通过减轻对肾微血管和小管上皮细胞的损伤来保护肾脏免受顺铂诱导的AKI(Cis-AKI),主要是通过免疫球蛋白- mir -874- 3d - p介导的抑制FZD5的激活和促进Wnt/β-catenin通路的激活。
{"title":"Cisplatin-induced acute kidney injury is alleviated by BMSCs-derived exosome via mmu-miR-874-3p-mediated activation of the wnt/β-catenin signaling pathway","authors":"Deyang Kong ,&nbsp;Zhuohang Yang ,&nbsp;Xiaoting Zhang ,&nbsp;Yifan Song ,&nbsp;Umer Anayyat ,&nbsp;Yanping Li ,&nbsp;Hao Liu ,&nbsp;Zhanci Ou ,&nbsp;Shuo Pang ,&nbsp;Xiaomei Wang","doi":"10.1016/j.reth.2025.08.016","DOIUrl":"10.1016/j.reth.2025.08.016","url":null,"abstract":"<div><h3>Background</h3><div>Acute kidney injury (AKI) results from cisplatin chemotherapeutic agents in 30 %–46 % of patients, but clinically effective preventive and therapeutic approaches are lacking. Bone marrow mesenchymal stem cells-derived exosomes (BMSCs-exo) have potential in tissue repair, but the mechanism by which they attenuate cisplatin-induced kidney injury is unknown.</div></div><div><h3>Objective</h3><div>To explore the therapeutic effect of BMSCs-exo on cisplatin-induced AKI and to analyze the key molecular mechanism involved.</div></div><div><h3>Methods and materials</h3><div>BMSCs-exo were extracted via ultracentrifugation and identified via transmission electron microscopy, nanoparticle analysis and Western blot. C57BL/6 mice were divided into a control group (Con), a cisplatin model group (Cis), and a BMSCs-exo treatment group (BMSCs-exo), and renal function was dynamically tested. PAS staining was used to observe histopathological changes in mouse kidney tissues, while immunohistochemistry was employed to assess the expression levels of Wnt4, β-catenin, FZD5, CD31, and the tubular injury markers NGAL and KIM1. Western blot was used to detect the expression of Wnt4, β-catenin, FZD5 and CD31. High-throughput sequencing was used to screen for differential miRNAs, and GO/KEGG enrichment analysis of target genes was performed.</div></div><div><h3>Results</h3><div>Blood creatinine and urea nitrogen levels were significantly higher in the Cis group than in the Con group, and renal tubular epithelial cells exhibited necrosis, confirming successful AKI model establishment. BMSCs-exo alleviated renal dysfunction, histopathological alterations, and tubular injury in vivo, as evidenced by NGAL and KIM1 expression. We further demonstrated that BMSCs-exo specifically localized to the injured kidney. MiRNA sequencing of renal tissues from the Con, Cis and BMSCs-exo groups identified mmu-miR-874-3p—enriched in Wnt signaling and angiogenesis pathways—as a key mediator of the renoprotective effects of BMSCs-exo, with FZD5 as its downstream target. Moreover, treatment with BMSCs-exo markedly prevented microvascular loss. In the BMSCs-exo group, Wnt4, β-catenin and CD31 expression were upregulated, whereas FZD5 expression was downregulated, consistent with the immunohistochemistry results.</div></div><div><h3>Conclusions</h3><div>BMSCs-exo protect kidneys against cisplatin-induced AKI(<em>Cis</em>-AKI) by attenuating injury to the renal microvasculature and tubule epithelial cells, primarily through mmu-miR-874-3p-mediated inhibition of FZD5 activation and promotion of Wnt/β-catenin pathway activation.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 719-729"},"PeriodicalIF":3.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144925616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exosomes derived from platelet-rich plasma promote hair regeneration by regulating the SIRT1/FoxO3a pathway to alleviate oxidative stress 来自富血小板血浆的外泌体通过调节SIRT1/FoxO3a通路促进毛发再生,从而减轻氧化应激
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-25 DOI: 10.1016/j.reth.2025.08.005
Xin Yang , Ke Wang , Guanmao Liu , Yuanju Chen , Ying Wang , Yujing Cheng , Chan Zhang

Introduction

Alopecia is a common disorder that severely affects the mental well-being and quality of life of those affected, yet available treatment options remain limited. Emerging evidence suggests that exosomes from diverse cellular sources possess therapeutic potential for alopecia. However, research on the application of platelet-rich plasma-derived exosomes (PRP-exos) in promoting hair growth is still relatively sparse. This study aims to elucidate the effects of PRP-exos on hair growth and to investigate the associated molecular mechanisms.

Methods

We employed conventional molecular biology techniques to evaluate the impacts of PRP-exos on hair follicle stem cells (HFSCs) in terms of proliferation, apoptosis, and migration, as well as their protective effects against oxidative stress. A murine model of alopecia was utilized, and the effectiveness of subcutaneously administered PRP-exos on hair growth was assessed through histological analysis. Additionally, RNA sequencing (RNA-seq) was conducted to explore the potential pathways mediating the effects of PRP-exos on hair growth.

Results

Our results demonstrate that PRP-exos significantly enhance both the proliferation and migration of HFSCs while concurrently inhibiting apoptosis and mitigating oxidative stress-induced damage. The subcutaneous injection of PRP-exos fostered hair regeneration in mice, marked by an increase in hair follicle counts of the anagen phase and dermal thickening. Importantly, we found that treatment with PRP-exos upregulated the expression of SIRT1, leading to the deacetylation of FoxO3a and a subsequent reduction in oxidative stress effects.

Conclusions

Ultimately, our findings suggest that PRP-exos facilitate hair regeneration by modulating the SIRT1/FoxO3a pathway, providing more evidence for their clinical application in alopecia management.
脱发是一种常见的疾病,严重影响患者的精神健康和生活质量,但可用的治疗选择仍然有限。新出现的证据表明,来自不同细胞来源的外泌体具有治疗脱发的潜力。然而,关于富血小板血浆源性外泌体(PRP-exos)在促进毛发生长中的应用研究仍然相对较少。本研究旨在阐明PRP-exos对头发生长的影响,并探讨其相关的分子机制。方法采用常规分子生物学技术,研究PRP-exos对毛囊干细胞(hscs)增殖、凋亡、迁移的影响及其对氧化应激的保护作用。利用小鼠脱发模型,通过组织学分析评估皮下给药PRP-exos对毛发生长的影响。此外,我们还进行了RNA测序(RNA-seq)来探索PRP-exos对头发生长影响的潜在途径。结果PRP-exos可显著促进HFSCs的增殖和迁移,同时抑制细胞凋亡,减轻氧化应激引起的损伤。皮下注射PRP-exos促进了小鼠的毛发再生,其特征是毛发生长期毛囊数量增加,真皮增厚。重要的是,我们发现用PRP-exos处理上调SIRT1的表达,导致FoxO3a的去乙酰化和随后氧化应激效应的降低。结论PRP-exos通过调节SIRT1/FoxO3a通路促进头发再生,为其在脱发治疗中的临床应用提供了更多证据。
{"title":"Exosomes derived from platelet-rich plasma promote hair regeneration by regulating the SIRT1/FoxO3a pathway to alleviate oxidative stress","authors":"Xin Yang ,&nbsp;Ke Wang ,&nbsp;Guanmao Liu ,&nbsp;Yuanju Chen ,&nbsp;Ying Wang ,&nbsp;Yujing Cheng ,&nbsp;Chan Zhang","doi":"10.1016/j.reth.2025.08.005","DOIUrl":"10.1016/j.reth.2025.08.005","url":null,"abstract":"<div><h3>Introduction</h3><div>Alopecia is a common disorder that severely affects the mental well-being and quality of life of those affected, yet available treatment options remain limited. Emerging evidence suggests that exosomes from diverse cellular sources possess therapeutic potential for alopecia. However, research on the application of platelet-rich plasma-derived exosomes (PRP-exos) in promoting hair growth is still relatively sparse. This study aims to elucidate the effects of PRP-exos on hair growth and to investigate the associated molecular mechanisms.</div></div><div><h3>Methods</h3><div>We employed conventional molecular biology techniques to evaluate the impacts of PRP-exos on hair follicle stem cells (HFSCs) in terms of proliferation, apoptosis, and migration, as well as their protective effects against oxidative stress. A murine model of alopecia was utilized, and the effectiveness of subcutaneously administered PRP-exos on hair growth was assessed through histological analysis. Additionally, RNA sequencing (RNA-seq) was conducted to explore the potential pathways mediating the effects of PRP-exos on hair growth.</div></div><div><h3>Results</h3><div>Our results demonstrate that PRP-exos significantly enhance both the proliferation and migration of HFSCs while concurrently inhibiting apoptosis and mitigating oxidative stress-induced damage. The subcutaneous injection of PRP-exos fostered hair regeneration in mice, marked by an increase in hair follicle counts of the anagen phase and dermal thickening. Importantly, we found that treatment with PRP-exos upregulated the expression of SIRT1, leading to the deacetylation of FoxO3a and a subsequent reduction in oxidative stress effects.</div></div><div><h3>Conclusions</h3><div>Ultimately, our findings suggest that PRP-exos facilitate hair regeneration by modulating the SIRT1/FoxO3a pathway, providing more evidence for their clinical application in alopecia management.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 710-718"},"PeriodicalIF":3.5,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144893482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Regenerative Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1